nb-dnj

L-NBDNJ is a sugar mimic and an antivirulence agent. It disrupts the expression of proteins that regulate the assembly and organization of the host cell cytoskeleton. In cystic fibrosis (CF) lung disease infection models, L-NBDNJ exhibits both anti-inflammatory and anti-infective properties.

Miglustat (NB-DNJ) is an alkylated product of imino sugar deoxynojirimycin.It is an inhibitor of glucosylceramide synthase, primarily to treat Type I Gaucher disease (GD1).

Miglustat hydrochloride (N-Butyldeoxynojirimycin hydrochloride) is an inhibitor of glucosylceramide synthase and can be used for studies about Type I Gaucher disease.